CRISPR beyond: harnessing compact RNA-guided endonucleases for enhanced genome editing
- 12 July 2024
- journal article
- review article
- Published by Springer Nature in Science China Life Sciences
- Vol. 67 (12) , 2563-2574
Abstract
The CRISPR-Cas system, an adaptive immunity system in prokaryotes designed to combat phages and foreign nucleic acids, has evolved into a groundbreaking technology enabling gene knockout, large-scale gene insertion, base editing, and nucleic acid detection. Despite its transformative impact, the conventional CRISPR-Cas effectors face a significant hurdle—their size poses challenges in effective delivery into organisms and cells. Recognizing this limitation, the imperative arises for the development of compact and miniature gene editors to propel advancements in gene-editing-related therapies. Two strategies were accepted to develop compact genome editors: harnessing OMEGA (Obligate Mobile Element-guided Activity) systems, or engineering the existing CRISPR-Cas system. In this review, we focus on the advances in miniature genome editors based on both of these strategies. The objective is to unveil unprecedented opportunities in genome editing by embracing smaller, yet highly efficient genome editors, promising a future characterized by enhanced precision and adaptability in the genetic interventions.Keywords
This publication has 108 references indexed in Scilit:
- Improve meat production and virus resistance by simultaneously editing multiple genes in livestock using Cas12iMaxScience China Life Sciences, 2023
- An optimized prime editing system for efficient modification of the pig genomeScience China Life Sciences, 2023
- Developing an efficient and visible prime editing system to restore tobacco 8-hydroxy-copalyl diphosphate gene for labdane diterpene Z-abienol biosynthesisScience China Life Sciences, 2023
- Develop a Compact RNA Base Editor by Fusing ADAR with Engineered EcCas6eAdvanced Science, 2023
- Computer-aided engineering of CRISPR-Cas proteins for enhanced human genome editingScience China Life Sciences, 2022
- CRISPR-CasRx knock-in mice for RNA degradationScience China Life Sciences, 2022
- Gene editing and its applications in biomedicineScience China Life Sciences, 2022
- Applications of the versatile CRISPR‐Cas13 RNA targeting systemWIREs RNA, 2021
- CRISPR/Cas9-mediated correction of human genetic diseaseScience China Life Sciences, 2017
- CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapyScience China Life Sciences, 2017